Ticker history: PTWO became SBC (SBC Medical Group Holdings Incorporated) on . Earlier news and filings retain their original names and dates. View PTWO history.
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SBC SEC filings page.
SBC Medical Group Holdings Incorporated (SBC) reported $190.4M in revenue over the twelve months to Sep 30, 2026, up 6.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue contracted, but operating costs absorbed much of the decline, leaving profit higher while cash conversion remained uneven.
Profit and cash moved apart: FY2025 net income reached$51.0M while operating cash flow was$24.7M . Cash generation equaled only48.4% of net income, so accounting earnings did not translate cleanly into spendable cash.
Revenue fell
Assets expanded
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of SBC Medical Group Holdings Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. SBC Medical Group Holdings Incorporated scores 95/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. SBC Medical Group Holdings Incorporated scores 16/100 on it among other operating companies.
SBC Medical Group Holdings Incorporated held more cash than long-term debt at the end of fiscal year 2025, with $163.8M of cash against $42.8M of long-term debt. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and SBC Medical Group Holdings Incorporated scores 93/100 among other operating companies measured the same way.
SBC Medical Group Holdings Incorporated held $3.78 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 3.78. Liquidity ranks operating companies on that ratio, and SBC Medical Group Holdings Incorporated scores 86/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. SBC Medical Group Holdings Incorporated scores 75/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. SBC Medical Group Holdings Incorporated scores 89/100 on it among other operating companies.
SBC Medical Group Holdings Incorporated scores 5.18, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $530.3M against total liabilities of $117.1M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
SBC Medical Group Holdings Incorporated passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, SBC Medical Group Holdings Incorporated generates $0.48 in operating cash flow ($24.7M OCF vs $51.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
SBC Medical Group Holdings Incorporated earns $455.26 in operating income for every $1 of interest expense ($67.5M vs $148K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
SBC Medical Group Holdings Incorporated generated $58.6M in revenue in Q3 2026. This represents an increase of 35.1% from the same quarter a year earlier. Against the prior quarter it is up 19.1%.
SBC Medical Group Holdings Incorporated's EBITDA was $27.6M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 66.0% from the same quarter a year earlier. Against the prior quarter it is up 37.3%.
SBC Medical Group Holdings Incorporated reported $15.7M in net income in Q3 2026. This represents an increase of 22.4% from the same quarter a year earlier. Against the prior quarter it is up 46.8%.
SBC Medical Group Holdings Incorporated earned $0.15 per diluted share (EPS) in Q3 2026. This represents an increase of 25.0% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.
Cash & Balance Sheet
SBC Medical Group Holdings Incorporated generated $17.5M in free cash flow in Q3 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 22.0%.
SBC Medical Group Holdings Incorporated held $198.4M in cash against $33.6M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
SBC Medical Group Holdings Incorporated's gross margin was 72.0% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.
SBC Medical Group Holdings Incorporated's operating margin was 45.1% in Q3 2026, reflecting core business profitability. This is up 8.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.5 percentage points.
SBC Medical Group Holdings Incorporated's net profit margin was 26.8% in Q3 2026, showing the share of revenue converted to profit. This is down 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.1 percentage points.
SBC Medical Group Holdings Incorporated's quarterly ROE was 5.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.
Capital Allocation
SBC Medical Group Holdings Incorporated repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
SBC Medical Group Holdings Incorporated invested $1.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 2234.4% from the same quarter a year earlier. Against the prior quarter it is up 1090.9%.
Not reported for Q3 2026.
SBC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58.6M+35.1% | $49.2M+13.4% | $43.1M-9.0% | $39.6M-10.9% | $43.4M-18.3% | $43.4M-18.3% | $47.3M-13.6% | $44.4M |
| Cost of Revenue | $16.4M+28.7% | $13.2M-1.0% | $12.7M+32.5% | $10.6M+0.9% | $12.7M+29.4% | $13.3M-2.4% | $9.6M-37.2% | $10.5M |
| Gross Profit | $42.2M+37.8% | $36.0M+19.9% | $30.3M-19.6% | $28.9M-14.6% | $30.6M-29.2% | $30.0M-23.9% | $37.7M-4.5% | $33.9M |
| SG&A Expenses | $15.8M+7.0% | $17.0M+10.1% | $12.6M-6.7% | $16.1M+15.8% | $14.7M-11.2% | $15.5M+27.4% | $13.5M-10.1% | $13.9M |
| Operating Income | $26.4M+66.3% | $19.0M+30.3% | $17.7M-26.8% | $12.8M+172.4% | $15.9M+14.8% | $14.6M-46.7% | $24.2M-1.1% | $4.7M |
| EBITDA | $27.6M+66.0% | $20.1M+32.3% | $18.4M-25.9% | $13.5M+139.4% | $16.6M+11.9% | $15.2M-46.0% | $24.8M-2.5% | $5.6M |
| Interest Expense | $127K+182.6% | $126K+170.2% | $112K+2724.0% | $53K+325.4% | $45K+720.5% | $47K+528.7% | $4K+31.7% | $12K |
| Income Tax | $9.4M+65.3% | $7.8M-29.5% | $7.5M-24.4% | $4.3Mn/m | $5.7M-44.8% | $11.1M+30.1% | $10.0M+17.8% | -$489K |
| Net Income | $15.7M+22.4% | $10.7M+335.0% | $11.3M-47.4% | $14.2M+117.2% | $12.8M+352.7% | $2.5M-86.7% | $21.5M+14.6% | $6.5M |
| EPS (Basic) | $0.15+25.0% | $0.10+400.0% | $0.11-47.6% | $0.14+133.3% | $0.12+300.0% | $0.02-90.0% | $0.21+5.0% | $0.06-60.0% |
| EPS (Diluted) | $0.15+25.0% | $0.10+400.0% | $0.11-47.6% | $0.14+133.3% | $0.12+300.0% | $0.02-90.0% | $0.21+5.0% | $0.06-60.0% |
| Diluted Shares (Avg) | 103M-0.1% | 103M-0.9% | 103M-0.7% | N/A | 103M+7.9% | 104M+9.9% | 103M+9.6% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
SBC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $424.8M+32.2% | $406.7M+29.0% | $388.0M+36.3% | $380.4M+43.0% | $321.4M+8.4% | $315.3M+1514.8% | $284.6M+1341.0% | $266.1M+2.8% |
| Current Assets | $273.9M+20.5% | $259.4M+7.5% | $238.8M+11.0% | $231.2M+25.4% | $227.2M+12.4% | $241.3M+16612.4% | $215.1M+12056.5% | $184.5M+11.2% |
| Cash & Equivalents | $198.4M+55.7% | $184.3M+20.7% | $167.3M+26.7% | $163.8M+31.0% | $127.4M-7.3% | $152.7M+10929.5% | $132.1M+7856.4% | $125.0M+21.4% |
| Short-Term Investments | $318K | $308K | $314K | $319Kn/m | N/A | N/A | N/A | $0n/m |
| Inventory | $2.9M+75.8% | $3.0M+74.7% | $2.3M+37.1% | $2.8M+86.8% | $1.7M-15.5% | $1.7M | $1.7M | $1.5M-51.6% |
| Long-Term Investments | $1.9M | $1.3M | $1.2M | $1.3M-57.4% | N/A | N/A | N/A | $3.0M+259.1% |
| Goodwill | $15.1M+206.1% | $15.2M+202.9% | $15.4M+222.1% | $15.4M+234.5% | $4.9M+38.9% | $5.0M | $4.8M | $4.6M+28.5% |
| Total Liabilities | $121.4M+65.5% | $126.7M+79.4% | $117.6M+101.8% | $117.1M+64.8% | $73.3M-19.4% | $70.6M+730.2% | $58.3M+591.7% | $71.1M-38.2% |
| Current Liabilities | $74.7M+67.5% | $78.5M+29.3% | $62.6M+29.1% | $61.1M-0.1% | $44.6M-38.4% | $60.7M+1253.1% | $48.5M+1001.3% | $61.2M-33.8% |
| Non-Current Liabilities | $46.7M+62.6% | $48.3M+384.5% | $55.1M+460.9% | $56.0M+467.7% | $28.7M+54.9% | $10.0M+147.6% | $9.8M+143.9% | $9.9M-56.2% |
| Long-Term Debt | $33.6M+59.1% | $37.8M+431.7% | $40.4M+489.0% | $42.8M+549.0% | $21.1M+2466.1% | $7.1M | $6.9M | $6.6M |
| Total Equity | $286.8M+15.7% | $263.8M+7.9% | $255.3M+12.8% | $248.3M+27.3% | $248.0M+21.0% | $244.6M+2669.8% | $226.4M+2411.1% | $195.1M+37.2% |
| Retained Earnings | $278.1M+22.9% | $262.4M+23.0% | $251.8M+19.3% | $240.4M+26.9% | $226.2M+23.7% | $213.4Mn/m | $211.0Mn/m | $189.5M+32.6% |
Not reported in any period shown, so not listed: Accounts Receivable.
SBC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.5Mn/m | $22.5Mn/m | $9.2M+378.7% | $52.0Mn/m | -$20.9M-516.7% | -$8.3M-143.5% | $1.9M-47.6% | -$7.3M-126.2% |
| Depreciation & Amortization | $1.2M+57.7% | $1.1M+78.0% | $670K+6.7% | $674K-27.7% | $746K-26.7% | $636K-23.4% | $628K-38.3% | $932K-63.6% |
| Stock-Based Compensation | N/A | N/A | N/A | N/A | $0-100.0% | N/A | N/A | N/A |
| Capital Expenditures | $1.0M+2234.4% | $84K-72.5% | $125K-50.7% | $798K+35.1% | $43K-89.5% | $307K-64.5% | $254K-63.9% | $590K-90.5% |
| Free Cash Flow | $17.5Mn/m | $22.4Mn/m | $9.1M+443.7% | $51.2Mn/m | -$20.9M-554.7% | -$8.6M-147.2% | $1.7M-43.8% | -$7.9M-136.4% |
| Investing Cash Flow | -$5.1Mn/m | $565K-96.5% | -$528Kn/m | -$24.2Mn/m | -$12.2M-415.7% | $16.4Mn/m | -$979Kn/m | -$4.5Mn/m |
| Financing Cash Flow | -$5.1M-144.4% | -$2.0M-127.3% | -$1.8Mn/m | $19.8M+74.2% | $11.6M-1.1% | $7.2Mn/m | -$280Kn/m | $11.4Mn/m |
| Share Buybacks | $0-100.0% | N/A | N/A | $0n/m | $2.6M | N/A | N/A | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
SBC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.0%+1.4pp | 73.1%+3.9pp | 70.5%-9.3pp | 73.1%-3.1pp | 70.6%-10.8pp | 69.2%-5.0pp | 79.7%+7.6pp | 76.3% |
| Operating Margin | 45.1%+8.5pp | 38.6%+5.0pp | 41.1%-10.0pp | 32.5%+21.8pp | 36.6%+10.6pp | 33.6%-17.8pp | 51.1%+6.5pp | 10.6% |
| Net Margin | 26.8%-2.8pp | 21.7%+16.1pp | 26.3%-19.2pp | 35.9%+21.2pp | 29.6%+24.2pp | 5.7%-29.1pp | 45.4%+11.2pp | 14.7% |
| Return on Equity | 5.5%+0.3pp | 4.0%+3.0pp | 4.4%-5.1pp | 5.7%+2.4pp | 5.2%+3.8pp | 1.0%-208.3pp | 9.5%-198.5pp | 3.4% |
| Return on Assets | 3.7%-0.3pp | 2.6%+1.9pp | 2.9%-4.7pp | 3.7%+1.3pp | 4.0%+3.0pp | 0.8%-93.9pp | 7.6%-87.4pp | 2.5% |
| Current Ratio | 3.67-1.4x | 3.31-0.7x | 3.82-0.6x | 3.78+0.8x | 5.10+2.3x | 3.98+3.7x | 4.44+4.0x | 3.01+1.2x |
| Debt-to-Equity | 0.120.0x | 0.14+0.1x | 0.16+0.1x | 0.17+0.1x | 0.09+0.1x | 0.03 | 0.03 | 0.03 |
| Liabilities-to-Equity | 0.42+0.1x | 0.48+0.2x | 0.46+0.2x | 0.47+0.1x | 0.30-0.1x | 0.29-0.7x | 0.26-0.7x | 0.36-0.4x |
| Asset Turnover | 0.140.0x | 0.120.0x | 0.11-0.1x | 0.10-0.1x | 0.130.0x | 0.14-2.6x | 0.17-2.6x | 0.17 |
| FCF Margin | 29.9%+78.1pp | 45.6%+65.5pp | 21.1%+17.6pp | 129.3% | -48.3%-56.9pp | -19.9%-54.5pp | 3.5%-1.9pp | -17.8% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| SBC Medical Group Holdings Incorporated SBC | FY2025 | $173.6M | $51.0M | 29.4% | $530.3M | 76/100 |
| ICF International, Inc. ICFI | FY2025 | $1.9B | $91.6M | 4.9% | $1.4B | 49/100 |
| CRA International, Inc. CRAI | FY2025 | $751.6M | $54.8M | 7.3% | $1.4B | 61/100 |
| Roma Green Finance Limited ROMA | FY2026 | $1.2M | -$3.5M | N/A | $328.2M | 41/100 |
| Enigmatig Limited EGG | FY2025 | $4.5M | $560K | 12.6% | $226.6M | 62/100 |
| Huron Consulting Group Inc. HURN | FY2025 | $1.7B | $105.0M | 6.2% | $2.7B | 57/100 |
Where SBC Medical Group Holdings Incorporated Ranks
Frequently Asked Questions
SBC Medical Group Holdings Incorporated (SBC) reported $173.6M in total revenue for fiscal year 2025. This represents a -15.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
SBC Medical Group Holdings Incorporated (SBC) revenue declined by 15.5% year-over-year, from $205.4M to $173.6M in fiscal year 2025.
Yes, SBC Medical Group Holdings Incorporated (SBC) reported a net income of $51.9M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $51.0M, with a net profit margin of 29.4%.
SBC Medical Group Holdings Incorporated (SBC) had EBITDA of $70.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, SBC Medical Group Holdings Incorporated (SBC) had $163.8M in cash and equivalents against $42.8M in long-term debt.
SBC Medical Group Holdings Incorporated (SBC) had a gross margin of 73.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
SBC Medical Group Holdings Incorporated (SBC) had an operating margin of 38.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
SBC Medical Group Holdings Incorporated (SBC) had a net profit margin of 29.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
SBC Medical Group Holdings Incorporated (SBC) has a return on equity of 20.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
SBC Medical Group Holdings Incorporated (SBC) generated $23.3M in free cash flow during fiscal year 2025. This represents a 29.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
SBC Medical Group Holdings Incorporated (SBC) generated $24.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
SBC Medical Group Holdings Incorporated (SBC) had $380.4M in total assets as of fiscal year 2025, including both current and long-term assets.
SBC Medical Group Holdings Incorporated (SBC) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
SBC Medical Group Holdings Incorporated (SBC) had a current ratio of 3.78 as of fiscal year 2025, which is generally considered healthy.
SBC Medical Group Holdings Incorporated (SBC) had a debt-to-equity ratio of 0.17 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
SBC Medical Group Holdings Incorporated (SBC) had a liabilities-to-equity ratio of 0.47 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
SBC Medical Group Holdings Incorporated (SBC) had a return on assets of 13.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
SBC Medical Group Holdings Incorporated (SBC) trades at 10.2x earnings, its market capitalization divided by $51.9M net income, trailing 12 months to September 30, 2026. The market capitalization is $530.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
SBC Medical Group Holdings Incorporated (SBC) trades at 2.8x sales, its market capitalization divided by $190.4M revenue, trailing 12 months to September 30, 2026. The market capitalization is $530.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
SBC Medical Group Holdings Incorporated (SBC) has an Altman Z-Score of 5.18, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
SBC Medical Group Holdings Incorporated (SBC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
SBC Medical Group Holdings Incorporated (SBC) has an earnings quality ratio of 0.48x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
SBC Medical Group Holdings Incorporated (SBC) has an interest coverage ratio of 455.26x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
SBC Medical Group Holdings Incorporated (SBC) scores 76 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.